|
MAN1A2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.37499999994539E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.573310E-04 |
| Normal-vs-Stage2 |
3.883600E-03 |
| Normal-vs-Stage3 |
6.34559999990181E-07 |
| Normal-vs-Stage4 |
4.88300000001107E-06 |
| Stage1-vs-Stage2 |
9.405600E-01 |
| Stage1-vs-Stage3 |
1.098640E-01 |
| Stage1-vs-Stage4 |
1.901390E-01 |
| Stage2-vs-Stage3 |
2.397200E-01 |
| Stage2-vs-Stage4 |
2.658400E-01 |
| Stage3-vs-Stage4 |
9.178000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.55109999997205E-06 |
| Normal-vs-AfricanAmerican |
2.980300E-02 |
| Normal-vs-Asian |
4.4268000000125E-06 |
| Caucasian-vs-AfricanAmerican |
4.320000E-01 |
| Caucasian-vs-Asian |
3.056600E-01 |
| AfricanAmerican-vs-Asian |
1.453570E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.00219999866047E-08 |
| Normal-vs-Female |
1.159370E-04 |
| Male-vs-Female |
3.184000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.847300E-04 |
| Normal-vs-Age(41-60Yrs) |
4.89889999999438E-06 |
| Normal-vs-Age(61-80Yrs) |
3.66550000000521E-05 |
| Normal-vs-Age(81-100Yrs) |
4.938400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.753800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.820200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.222200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.636400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.964600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.735000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.641500E-03 |
| Classical-VS-Follicular |
2.971000E-01 |
| Classical-VS-Other |
1.296980E-01 |
| Classical-VS-Normal |
2.423000E-04 |
| Tall-VS-Follicular |
1.453430E-01 |
| Tall-VS-Other |
4.617200E-01 |
| Tall-VS-Normal |
3.42570000033682E-07 |
| Follicular-VS-Other |
2.508400E-01 |
| Follicular-VS-Normal |
9.72500000000487E-05 |
| Other-VS-Normal |
1.580500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.74990000000919E-05 |
| Normal-vs-N1 |
4.0004000000371E-06 |
| N0-vs-N1 |
1.648640E-01 |
|
|
